Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Azzi (Sydney, Australia), M. Peters (Sydney, Australia), V. Kritikos (Sydney, Australia), D. Price (Aberdeen, United Kingdom), P. Srour (Sydney, Australia), B. Cvetkovski (Sydney, Australia), S. Bosnic-Anticevich (Sydney, Australia). Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy.. 709

Member's Comments

No comment yet.

Related content which might interest you: Use of reliever medication and unscheduled medical care: who are this ashma patients? Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008 Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 Adherence to medication advice through a remote electronic asthma and COPD service Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective? Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 “My reliever helps me control my asthma”: patient attitudes to asthma inhalers Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Oral corticosteroid prescription patterns in asthma care in Italy Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Prescription of inhaled corticosteroids for COPD in general practice in Denmark – changes after participating in an educational programme Source: Annual Congress 2008 - Management of COPD Year: 2008 Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010 Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 The differences of medication use between women with persistent asthma receiving care from specialty and non-specialty clinics Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005 Prescribing patterns of antiasthma medication in children and adolescents in primary care in France. Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Antibiotic prescribing practises of hospital doctors for COPD exacerbations Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Improving asthma care with use of asthma action plan and inhaler technique check in a children‘s hospital Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Regular consultations with health care professionals enhance asthma treatment compliance. The results of ECRHS-II Source: Eur Respir J 2005; 26: Suppl. 49, 220s Year: 2005 SABA and ICS use among mild asthma patients in UK primary care Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 The use of electronic alerts in primary care to identify the over-prescription of short-acting beta2-agonists in people with asthma: a systematic review Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 The drug costs associated with COPD prescription medicine in Denmark Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 Over-the-counter (OTC) ß2-agonist purchase is not associated with poor asthma control: a random, community study Source: Eur Respir J 2006; 28: Suppl. 50, 685s Year: 2006